Overview

Angiochem, Inc. is a biotechnology company focused on creating innovative therapies for the treatment of brain diseases. The company leverages a deep understanding of drug delivery and the blood-brain barrier to develop therapeutic products that address unmet medical needs.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Angiochem, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.